vs
Grove Collaborative Holdings, Inc.（GROV）与RECURSION PHARMACEUTICALS, INC.（RXRX）财务数据对比。点击上方公司名可切换其他公司
Grove Collaborative Holdings, Inc.的季度营收约是RECURSION PHARMACEUTICALS, INC.的1.2倍（$42.4M vs $35.5M），Grove Collaborative Holdings, Inc.净利率更高（-3.7% vs -304.2%，领先300.5%），RECURSION PHARMACEUTICALS, INC.同比增速更快（681.7% vs -14.3%），Grove Collaborative Holdings, Inc.自由现金流更多（$-62.0K vs $-47.3M），过去两年RECURSION PHARMACEUTICALS, INC.的营收复合增速更高（60.5% vs -11.0%）
Grove Collaborative控股公司是一家公益企业，总部位于美国旧金山，在缅因州波特兰设有额外办事处。该企业以自有品牌Grove Co.推出并销售自有环保家居及个人护理产品，同时也代理销售其他品牌的相关产品，主打绿色可持续的日用消费品类目。
Recursion Pharmaceuticals是一家临床阶段生物技术企业，依托人工智能技术和高通量生物实验体系，开发针对罕见病、肿瘤、炎症性疾病等领域未满足医疗需求的创新疗法，核心市场覆盖北美，与全球多家生物制药企业合作推进在研管线落地。
GROV vs RXRX — 直观对比
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $42.4M | $35.5M |
| 净利润 | $-1.6M | $-108.1M |
| 毛利率 | 53.0% | 59.8% |
| 营业利润率 | -3.7% | -304.8% |
| 净利率 | -3.7% | -304.2% |
| 营收同比 | -14.3% | 681.7% |
| 净利润同比 | 87.5% | 39.6% |
| 每股收益（稀释后） | $-0.06 | $-0.17 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q4 25 | $42.4M | $35.5M | ||
| Q3 25 | $43.7M | $5.2M | ||
| Q2 25 | $44.0M | $19.2M | ||
| Q1 25 | $43.5M | $14.7M | ||
| Q4 24 | $49.5M | $4.5M | ||
| Q3 24 | $48.3M | $26.1M | ||
| Q2 24 | $52.1M | $14.4M | ||
| Q1 24 | $53.5M | $13.8M |
| Q4 25 | $-1.6M | $-108.1M | ||
| Q3 25 | $-3.0M | $-162.3M | ||
| Q2 25 | $-3.6M | $-171.9M | ||
| Q1 25 | $-3.5M | $-202.5M | ||
| Q4 24 | $-12.6M | $-178.9M | ||
| Q3 24 | $-1.3M | $-95.8M | ||
| Q2 24 | $-10.1M | $-97.5M | ||
| Q1 24 | $-3.4M | $-91.4M |
| Q4 25 | 53.0% | 59.8% | ||
| Q3 25 | 53.3% | -183.8% | ||
| Q2 25 | 55.4% | -4.9% | ||
| Q1 25 | 53.0% | -48.0% | ||
| Q4 24 | 52.4% | -181.4% | ||
| Q3 24 | 53.0% | 53.7% | ||
| Q2 24 | 53.9% | 36.2% | ||
| Q1 24 | 55.5% | 19.1% |
| Q4 25 | -3.7% | -304.8% | ||
| Q3 25 | -6.2% | -3327.6% | ||
| Q2 25 | -7.9% | -916.8% | ||
| Q1 25 | -8.1% | -1297.9% | ||
| Q4 24 | -16.8% | -4042.4% | ||
| Q3 24 | -14.0% | -377.1% | ||
| Q2 24 | -13.3% | -697.4% | ||
| Q1 24 | -1.0% | -698.4% |
| Q4 25 | -3.7% | -304.2% | ||
| Q3 25 | -6.8% | -3135.3% | ||
| Q2 25 | -8.2% | -894.2% | ||
| Q1 25 | -8.1% | -1373.3% | ||
| Q4 24 | -25.5% | -3935.5% | ||
| Q3 24 | -2.8% | -367.5% | ||
| Q2 24 | -19.3% | -676.6% | ||
| Q1 24 | -6.3% | -662.4% |
| Q4 25 | $-0.06 | $-0.17 | ||
| Q3 25 | $-0.08 | $-0.36 | ||
| Q2 25 | $-0.10 | $-0.41 | ||
| Q1 25 | $-0.10 | $-0.50 | ||
| Q4 24 | $-0.34 | $-0.56 | ||
| Q3 24 | $-0.04 | $-0.34 | ||
| Q2 24 | $-0.28 | $-0.40 | ||
| Q1 24 | $-0.10 | $-0.39 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $8.5M | $743.3M |
| 总债务越低越好 | — | $9.6M |
| 股东权益账面价值 | $-17.0M | $1.1B |
| 总资产 | $53.1M | $1.5B |
| 负债/权益比越低杠杆越低 | — | 0.01× |
8季度趋势，按日历期对齐
| Q4 25 | $8.5M | $743.3M | ||
| Q3 25 | $8.9M | $659.8M | ||
| Q2 25 | $10.0M | $525.1M | ||
| Q1 25 | $9.6M | $500.5M | ||
| Q4 24 | $19.6M | $594.4M | ||
| Q3 24 | $50.8M | $427.6M | ||
| Q2 24 | $78.8M | $474.3M | ||
| Q1 24 | $77.8M | $296.3M |
| Q4 25 | — | $9.6M | ||
| Q3 25 | — | $11.9M | ||
| Q2 25 | — | $14.2M | ||
| Q1 25 | — | $16.4M | ||
| Q4 24 | — | $19.0M | ||
| Q3 24 | $32.2M | $20.5M | ||
| Q2 24 | — | $22.9M | ||
| Q1 24 | — | — |
| Q4 25 | $-17.0M | $1.1B | ||
| Q3 25 | $-16.1M | $1.0B | ||
| Q2 25 | $-14.0M | $919.1M | ||
| Q1 25 | $-11.6M | $933.9M | ||
| Q4 24 | $-8.5M | $1.0B | ||
| Q3 24 | $1.5M | $524.6M | ||
| Q2 24 | $686.0K | $584.4M | ||
| Q1 24 | $7.5M | $401.2M |
| Q4 25 | $53.1M | $1.5B | ||
| Q3 25 | $54.6M | $1.4B | ||
| Q2 25 | $57.8M | $1.3B | ||
| Q1 25 | $59.8M | $1.3B | ||
| Q4 24 | $65.0M | $1.4B | ||
| Q3 24 | $105.2M | $726.5M | ||
| Q2 24 | $131.8M | $775.9M | ||
| Q1 24 | $137.9M | $557.8M |
| Q4 25 | — | 0.01× | ||
| Q3 25 | — | 0.01× | ||
| Q2 25 | — | 0.02× | ||
| Q1 25 | — | 0.02× | ||
| Q4 24 | — | 0.02× | ||
| Q3 24 | 21.16× | 0.04× | ||
| Q2 24 | — | 0.04× | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-29.0K | $-46.1M |
| 自由现金流经营现金流 - 资本支出 | $-62.0K | $-47.3M |
| 自由现金流率自由现金流/营收 | -0.1% | -133.1% |
| 资本支出强度资本支出/营收 | 0.1% | 3.5% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-8.1M | $-378.3M |
8季度趋势，按日历期对齐
| Q4 25 | $-29.0K | $-46.1M | ||
| Q3 25 | $-1.0M | $-117.4M | ||
| Q2 25 | $987.0K | $-76.4M | ||
| Q1 25 | $-6.9M | $-132.0M | ||
| Q4 24 | $270.0K | $-115.4M | ||
| Q3 24 | $750.0K | $-59.2M | ||
| Q2 24 | $1.6M | $-82.2M | ||
| Q1 24 | $-12.4M | $-102.3M |
| Q4 25 | $-62.0K | $-47.3M | ||
| Q3 25 | $-1.2M | $-117.6M | ||
| Q2 25 | $556.0K | $-79.6M | ||
| Q1 25 | $-7.4M | $-133.8M | ||
| Q4 24 | $-95.0K | $-116.7M | ||
| Q3 24 | $264.0K | $-63.8M | ||
| Q2 24 | $1.2M | $-83.4M | ||
| Q1 24 | $-12.9M | $-109.0M |
| Q4 25 | -0.1% | -133.1% | ||
| Q3 25 | -2.7% | -2272.5% | ||
| Q2 25 | 1.3% | -413.9% | ||
| Q1 25 | -17.0% | -907.4% | ||
| Q4 24 | -0.2% | -2567.7% | ||
| Q3 24 | 0.5% | -244.6% | ||
| Q2 24 | 2.3% | -578.5% | ||
| Q1 24 | -24.1% | -789.9% |
| Q4 25 | 0.1% | 3.5% | ||
| Q3 25 | 0.4% | 4.7% | ||
| Q2 25 | 1.0% | 16.4% | ||
| Q1 25 | 1.2% | 12.4% | ||
| Q4 24 | 0.7% | 28.6% | ||
| Q3 24 | 1.0% | 17.5% | ||
| Q2 24 | 0.7% | 8.2% | ||
| Q1 24 | 1.0% | 48.2% |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
GROV
| Third Party Products | $23.4M | 55% |
| Grove Brands | $19.0M | 45% |
RXRX
暂无分部数据
